Dec 7 (Reuters) - The Omicron variant of the coronavirus can partially evade the protection from Pfizer Inc and partner BioNTech's COVID-19 vaccine, Bloomberg News reported on Tuesday, citing the research head of a laboratory at Africa Health Research Institute in South Africa.
Its evasion is not complete and a booster shot could provide additional protection, according to the report https://bloom.bg/3ItWEj7, citing the researcher, Alex Sigal. (Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)
